[go: up one dir, main page]

HUP0200157A2 - A terméketlenség kezelése - Google Patents

A terméketlenség kezelése

Info

Publication number
HUP0200157A2
HUP0200157A2 HU0200157A HUP0200157A HUP0200157A2 HU P0200157 A2 HUP0200157 A2 HU P0200157A2 HU 0200157 A HU0200157 A HU 0200157A HU P0200157 A HUP0200157 A HU P0200157A HU P0200157 A2 HUP0200157 A2 HU P0200157A2
Authority
HU
Hungary
Prior art keywords
infertility
treatment
vitro fertilization
meiosis
activates
Prior art date
Application number
HU0200157A
Other languages
English (en)
Inventor
Christian Grondahl
Thomas Host Hansen
Christa Hegele-Hartung
Alexander Rübig
Original Assignee
Novo Nordisk A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk A/S filed Critical Novo Nordisk A/S
Publication of HUP0200157A2 publication Critical patent/HUP0200157A2/hu
Publication of HUP0200157A3 publication Critical patent/HUP0200157A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0608—Germ cells
    • C12N5/0609—Oocytes, oogonia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • C12N2501/392—Sexual steroids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2517/00—Cells related to new breeds of animals
    • C12N2517/10—Conditioning of cells for in vitro fecondation or nuclear transfer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A találmány emberek in vitro megtermékenyítési eljárására vonatkozik.Az in vitro megtermékenyítés meiózist aktiváló vegyülettel javítható. Ó
HU0200157A 1999-02-24 2000-02-23 Treatment of infertility HUP0200157A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA199900255 1999-02-24
US13081699P 1999-04-23 1999-04-23
DKPA199901310 1999-09-16

Publications (2)

Publication Number Publication Date
HUP0200157A2 true HUP0200157A2 (hu) 2002-05-29
HUP0200157A3 HUP0200157A3 (en) 2002-06-28

Family

ID=27220546

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0200157A HUP0200157A3 (en) 1999-02-24 2000-02-23 Treatment of infertility

Country Status (13)

Country Link
US (1) US6585982B1 (hu)
EP (1) EP1156822B1 (hu)
JP (1) JP2002537349A (hu)
KR (1) KR20010093280A (hu)
CN (1) CN1353617A (hu)
AT (1) ATE317266T1 (hu)
AU (1) AU2794100A (hu)
BR (1) BR0008468A (hu)
CZ (1) CZ20012967A3 (hu)
DE (1) DE60025905T2 (hu)
ES (1) ES2258445T3 (hu)
HU (1) HUP0200157A3 (hu)
WO (1) WO2000050066A1 (hu)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) * 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
CZ20012671A3 (cs) * 1999-02-26 2002-01-16 Novo Nordisk A/S Způsob in vitro oplodnění s pouľitím kultivačního média obsahujícího sterol aktivující meiosu
AU3376501A (en) * 2000-02-25 2001-09-03 Novo Nordisk A/S Improvement of implantation rate
MXPA02007818A (es) * 2000-02-25 2002-10-23 Schering Ag Tasa de implantacion mejorada utilizando ff-mas.
US20040224878A1 (en) * 2000-05-18 2004-11-11 Suna Cukurcam Fertilization of aged oocytes
US6995252B2 (en) * 2000-05-25 2006-02-07 Queen's University At Kingston PT32 sperm protein, sperm c-Yes, oocyte cytoplasmic c-Yes and uses thereof
EP1216701A1 (en) * 2000-12-22 2002-06-26 Schering Aktiengesellschaft Process to increase the concentration of meiosis-activating sterols (MAS) in the cholesterol synthesis and the use of potent inhibitors in the process
EP1245572A1 (en) 2001-03-26 2002-10-02 Schering Aktiengesellschaft Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation
ES2356895T3 (es) * 2001-09-12 2011-04-14 Merck Serono Sa USO DE LA hCG Y LH EN LA HIPERESTIMULACIÓN OVÁRICA CONTROLADA.
AU2002324183B2 (en) * 2001-09-12 2007-10-25 Merck Serono Sa Use of hCG and LH in controlled ovarian hyperstimulation
KR20040032954A (ko) 2001-09-12 2004-04-17 어플라이드 리서치 시스템스 에이알에스 홀딩 엔.브이. 과배란 유도에서 ｈＣＧ의 용도
WO2003070766A2 (en) * 2002-02-22 2003-08-28 Novo Nordisk A/S A transducer of mas signalling
CA2477743C (en) 2002-03-08 2011-11-08 Mcgill University In vitro maturation of immature human oocytes
MXPA04012246A (es) * 2002-06-07 2005-04-08 Ares Trading Sa Metodo para la hiperestimulacion ovarica controlada y equipo farmaceutico para usarlo en dicho metodo.
CA2569031A1 (en) 2004-05-17 2006-01-05 The General Hospital Corporation Methods and compositions for producing germ cells from bone marrow derived germline stem cells
MY154677A (en) 2006-03-07 2015-07-15 Shroff Geeta Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
SG10201406171QA (en) 2011-04-14 2014-10-30 Gen Hospital Corp Compositions and methods for autologous germline mitochondrial energy transfer
EP3495470A1 (en) 2011-06-29 2019-06-12 The General Hospital Corporation In vivo methods for enhancing bioenergetic status in female germ cells
US20150272622A1 (en) * 2011-12-22 2015-10-01 Previvo Genetics, Llc Recovery and processing of human embryos formed in vivo

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5563059A (en) * 1993-02-23 1996-10-08 Genentech, Inc. Use of human inhibin and human activin to increase the number of mature primate oocytes
US5716777A (en) * 1994-06-23 1998-02-10 Novo Nordisk A/S Regulation of meiosis using sterols
RU2188006C2 (ru) * 1995-03-06 2002-08-27 Ново Нордиск А/С Стимуляция мейоза
WO1997000883A1 (en) * 1995-06-23 1997-01-09 Novo Nordisk A/S Meiosis regulating compounds
EP0857173B1 (en) * 1995-06-23 2003-11-19 Novo Nordisk A/S Meiosis regulating compounds
ATE238339T1 (de) * 1996-12-20 2003-05-15 Novo Nordisk As Verbindungen zur regulierung der meiose
PL337188A1 (en) * 1997-06-04 2000-08-14 Akzo Nobel Nv Derivatives of 17beta - allyloxy (thio) alkyl - androstane for modulation of meiosis
US5866599A (en) * 1997-06-06 1999-02-02 Basf Aktiengesellschaft Fungicidal mixtures
AU2794000A (en) * 1999-02-24 2000-09-14 Novo Nordisk A/S Treatment of infertility

Also Published As

Publication number Publication date
KR20010093280A (ko) 2001-10-27
BR0008468A (pt) 2002-02-05
JP2002537349A (ja) 2002-11-05
HUP0200157A3 (en) 2002-06-28
ES2258445T3 (es) 2006-09-01
EP1156822A1 (en) 2001-11-28
ATE317266T1 (de) 2006-02-15
US6585982B1 (en) 2003-07-01
DE60025905T2 (de) 2006-09-14
WO2000050066A1 (en) 2000-08-31
AU2794100A (en) 2000-09-14
DE60025905D1 (de) 2006-04-20
EP1156822B1 (en) 2006-02-08
CN1353617A (zh) 2002-06-12
CZ20012967A3 (cs) 2001-12-12

Similar Documents

Publication Publication Date Title
HUP0200157A2 (hu) A terméketlenség kezelése
UY26249A1 (es) Moléculas pequenas útiles en el tratamiento de las enfermedades inflamatorias ley 17164 art. 127
MX9703868A (es) Inhibidores de cgmp-pde para el tratamiento de disfuncion erectil.
HN1996000082A (es) Compuestos de quinolina y quinozssolina utiles en terapia.
TR200103525T2 (tr) Bisiklik poliaminosit metal kompleksleri, bunları hazırlamak için yöntem ve bunların tıbbi görüntülemede kullanımı.
PT1143967E (pt) Utilizacao de derivados anticonvulsivos para o tratamento de cefaleias em salvas
TR199701073T1 (xx) Protein kinaz C inhibit�rleri.
WO2003103653A8 (en) METHODS OF TREATING ALZHEIMER'S DISEASE WITH ALKANOIC ARYL ACID AMIDES
HN2000000268A (es) Compuestos , composiciones y metodos para estimular el crecimiento y elongacion de neuronas
DE60239558D1 (de) Kombinationen für die behandlung von immun-entzündlichen erkrankungen
ZA200000523B (en) Process for the treatment of steel work gases.
AU5173501A (en) Polyamine analogues as cytotoxic agents
NO20013880D0 (no) Matriks og fremgangsmate for fremstilling av polyolefin
NI200300045A (es) Inhibidores de triariloxiariloxipirimidin-2,4,6-triona de metaloproteinasa.
IL163951A (en) Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
EP1492902A4 (en) COMPOSITION AND PROCESS FOR TREATING METAL SURFACES
DE59801385D1 (de) Durchlaufanlage für die behandlung von werkstücken
MXPA03011502A (es) Aminoalcoholes sustituidos utiles en tratamiento de enfermedad de alzheimer.
TR200103125T2 (tr) Otizmin iyileştirilmesinde kullanıma yönelik antikonvülsan türevleri.
BG104801A (en) Indole-2,3-dione-3-oxime derivatives for therapeutical use
PT1152762E (pt) Utilizacao de desoxipeganina no tratamento da demencia de alzheimer
DE60226313D1 (de) Verwendung von sesquiterpene enthaltenden zusammenstellungen zur behandlung von krebs
HUP0202630A2 (hu) Meiózisra ható anyagokat tartalmazó készítmények
IT1311213B1 (it) Procedimento e impianto perfezionato per il trattamento deimateriali nella produzione di corpi cavi in p.e.t.
DE60201440D1 (de) Aryl-8-azabicyclo[3.2.1]octanes für die behandlung von depression